Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

EPIDURAL KETAMINE - A PRELIMINARY-REPORT SOUTH AFRICAN MEDICAL JOURNAL MANKOWITZ, E., BROCKUTNE, J. G., Cosnett, J. E., GREENTHOMPSON, R. 1982; 61 (12): 441-442

Abstract

Ketamine hydrochloride 4 mg in 10 ml 5% dextrose water was administered epidurally to 7 patients suffering from intractable pain in the back, lower abdomen and legs. Pain relief was obtained in all cases. The duration of action varied from half an hour to more than 6 hours. No adverse side-effects were noted and no detectable neurological damage resulted. Intraspinal ketamine offers and advantage over the opiates, in that respiratory depression is unlikely to occur.

View details for Web of Science ID A1982NG35200020

View details for PubMedID 7064021